Skip to main content
Year archive

Biotest AG — 2021 filings

All 73 regulatory filings released by Biotest AG (BIO3) in 2021, sourced directly from the official regulator.

73 Filings
2021 Period
2021 filings (73)
Filing Released Lang
Biotest AG: Biotest treats first CMV-positive pregnant woman in Phase III clinical trial to prevent transmission of CMV infection to the unborn child
Regulatory Filings
2021-12-14 English
Biotest AG: Biotest Supervisory Board appoints new Management Board member
Board/Management Information
2021-12-09 English
Biotest AG: Biotest adjusts guidance
Earnings Release FY 2021
2021-12-08 English
Biotest AG: Reduction of guidance
Earnings Release FY 2021
2021-12-08 English
Biotest AG: Biotest receives approval for Intratect(R) in France
Regulatory Filings
2021-11-30 English
DGAP-DD: Biotest AG english
Director's Dealing
2021-11-29 English
Biotest AG: Biotest AG opens seventh plasma collection centre in Czech Republic
Regulatory Filings
2021-11-25 English
Biotest AG: Biotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR
Earnings Release Q4 2021
2021-11-23 English
DGAP-DD: Biotest AG english
Director's Dealing
2021-11-18 English
DGAP-DD: Biotest AG english
Director's Dealing
2021-11-18 English
DGAP-DD: Biotest AG english
Director's Dealing
2021-11-18 English
DGAP-DD: Biotest AG english
Director's Dealing
2021-11-18 English
Biotest AG: Cytotect CP(R) Biotest activates immune cells that are crucial to control Cytomegalovirus
Regulatory Filings
2021-11-16 English
Biotest AG: Biotest increases sales by 9% in the first nine months 2021
Earnings Release 9M 2021
2021-11-11 English
Earnings Release 2021
Earnings Release 9M 2021
2021-11-11 English
Investor Presentation 2021
Investor Presentation
2021-11-11 English
Q3 statement / Q3 financial report 2021
Interim / Quarterly Report 9M 2021
2021-11-11 English
Biotest AG: Joint reasoned statement of Biotest AG - Management Board and Supervisory Board recommend to accept takeover offer of GRIFOLS, S.A.
M&A Activity
2021-11-05 English
Biotest AG: Biotest identifies a benefit with trimodulin in a relevant subgroup of hospitalised COVID-19 patients
Regulatory Filings
2021-10-11 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-09-20 English
Biotest AG: Takeover Offer: Grifols S.A. to make a voluntary public takeover offer for the shares of Biotest AG
M&A Activity
2021-09-17 English
Biotest AG: Biotest announces the new Renate & Hans Schleussner Award for scientific research
Environmental & Social Information
2021-09-15 English
Biotest AG: Biotest receives approval for phase III clinical trial in pregnant women for prevention of CMV infection of the unborn baby
Regulatory Filings
2021-08-26 English
Biotest AG: Biotest AG opens sixth plasma collection centre in Czech Republic
Regulatory Filings
2021-08-23 English
Biotest AG: Trimodulin does not reach the primary endpoint in the phase II trial in patients with severe COVID-19
Legal Proceedings Report
2021-08-13 English
Biotest AG: Biotest increases sales by 10% in the first half of 2021
Earnings Release H1 2021
2021-08-12 English
Halbjahresfinanzbericht
Interim / Quarterly Report H1 2021
2021-08-12 German
Interim / Quarterly Report 2021
Interim / Quarterly Report H2 2021
2021-08-12 German
Interim / Quarterly Report 2021
Interim / Quarterly Report H2 2021
2021-08-12 English
Half-yearly financial report 2021
Interim / Quarterly Report H2 2021
2021-08-12 German
Biotest AG: Biotest proves the mode of action of trimodulin for the treatment of COVID-19
Regulatory Filings
2021-08-03 English
Biotest AG: Biotest AG opens 11th plasma collection centre in Hungary
Regulatory Filings
2021-07-20 English
Ergänzung der Veröffentlichung vom 02.06.2021
AGM Information
2021-07-14 German
Biotest AG: Biotest receives manufacturing license for new production facility and plans to hire 150 additional employees
Regulatory Filings
2021-07-13 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Report Publication Announcement 2021
Report Publication Announcement
2021-07-06 English
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
Report Publication Announcement
2021-07-06 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2021 bis zum 30.06.2021
Report Publication Announcement
2021-07-06 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2020 bis zum 30.06.2020
Report Publication Announcement
2021-07-06 German
Hinweis auf Jahresfinanzbericht vom 01.01.2020 bis zum 31.12.2020
Report Publication Announcement
2021-07-06 German
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2021 bis zum 30.09.2021
Report Publication Announcement
2021-07-06 German
Hinweis auf Jahresfinanzbericht vom 31.01.2020 bis zum 31.12.2020
Report Publication Announcement
2021-07-06 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
Report Publication Announcement
2021-07-06 German
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2021 bis zum 31.03.2021
Report Publication Announcement
2021-07-06 German
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
Report Publication Announcement
2021-07-06 German
Biotest AG: Biotest AG opens fifth plasma collection centre in Czech Republic
Regulatory Filings
2021-06-30 English
Biotest AG: Biotest successfully completes recruitment for its clinical trial with trimodulin in severe COVID-19 patients
Regulatory Filings
2021-06-02 English
Ergänzt am 14.07.2021
Report Publication Announcement
2021-06-02 German
Biotest AG: Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR)
Major Shareholding Notification
2021-06-01 English
Correction of a release from 11/05/2021, 14:30 CET/CEST - Biotest AG: Annual General Meeting approves dividend distribution
AGM Information
2021-05-11 English
Biotest AG: Annual General Meeting approves dividend distribution
AGM Information
2021-05-11 English
Biotest AG: Biotest increases sales by more than 22 % in the first quarter of 2021 to 120 million EUR
Earnings Release Q1 2021
2021-05-11 English
Q1 statement / Q1 financial report 2021
Interim / Quarterly Report Q1 2021
2021-05-11 German
Biotest AG: Biotest AG opens 10th plasma collection centre in Hungary
Regulatory Filings
2021-05-06 English
Biotest AG: Biotest confirms good tolerability and efficacy of Intratect(R) in primary and secondary immunodeficiencies in an observational study
Regulatory Filings
2021-04-22 English
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 11.05.2021 in Dreieich mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2021-04-21 German
Biotest AG: Biotest accelerates fibrinogen phase III study with additional patient group
Legal Proceedings Report
2021-04-07 English
Biotest AG: Biotest exceeds Sales and EBIT forecast in the 2020 financial year
Earnings Release FY 2020
2021-03-31 English
Annual financial report 2020
Annual Report FY 2020
2021-03-31 English
Geschäftsbericht 2020
Annual Report FY 2020
2021-03-31 German
Investor Presentation 2021
Investor Presentation
2021-03-31 German
Investor Presentation 2021
Investor Presentation
2021-03-31 English
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 11.05.2021 in Dreieich mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2021-03-30 German
Biotest AG: Biotest supports clinical study with Pentaglobin(R) in COVID-19 at the University Hospital AKH Vienna
Regulatory Filings
2021-02-23 English
Biotest AG: Biotest is the first plasma protein manufacturer in Germany to produce an investigational hyperimmunoglobulin preparation against COVID-19 and can provide further production capacities
Regulatory Filings
2021-02-18 English
Biotest AG: Biotest significantly exceeds Revenue and EBIT guidance
Earnings Release FY 2020
2021-02-11 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-01 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-11 English